Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)

Clinical Trial

NCT04125927 Completed

Open-label, Single-arm, Multicenter Study to Assess the Safety of Cystadrops® in Pediatric Cystinosis Patients From 6 Months to Less Than 2 Years Old

Phase 3

Interventional

Disease

Disease type

Other

Paediatric clinical trials

Orphan drug recognition

Yes

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

01/09/2020

Closing date

23/12/2022

Inclusion criteria :

Exclusion criteria :

Funding

other

Members involved

Others investigators

Pr Ingele Casteels

Representative

Belgium

Pr Dominique BREMOND-GIGNAC

Representative

France

Anterior Segment Rare Eye Diseases (WG4), CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)

Working Group Leader